Taiwan FDA registration bd186be603a8ac442cc2d23b7a97e3d9
Abbott Murex Anti-HCV (Version 4.0)
TW: 亞培"妙芮絲" C型肝炎病毒抗體檢驗試劑(第四代)
Taiwan·Risk Class 3·MD·DIASORIN S.P.A. UK BRANCH·Registered Jan 10, 2019 – Jan 10, 2024ExpiredRegistration details
- Analysis ID
- bd186be603a8ac442cc2d23b7a97e3d9
- License Form
- Ministry of Health Medical Device Import No. 032111
- Customs Code
- DHA05603211103
Company information
- Manufacturer
- DIASORIN S.P.A. UK BRANCH
- Manufacturer Country
- United Kingdom
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product uses enzyme immunoassay to test for hepatitis C virus (HCV) antibodies in human serum or plasma.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B4020 Analyze specific reagents
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 10, 2019
- Expiry Date
- Jan 10, 2024
About this record
Access comprehensive regulatory information for Abbott Murex Anti-HCV (Version 4.0) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number bd186be603a8ac442cc2d23b7a97e3d9 and manufactured by DIASORIN S.P.A. UK BRANCH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices